OBJECTIVE- To test the hypothesis that latencies of evoked potentials
in IDDM patients are delayed compared with healthy control subjects du
ring euglycemia, and that insulin-induced hypoglycemia causes further
latency delays of evoked potentials to occur. RESEARCH DESIGN AND METH
ODS- we recruited 23 IDDM patients (27.9 +/- 1.6 yr of age, HbA1c 6.7
+/- 0.3%, without sensory or autonomic neuropathy) and 26 unequivocall
y healthy subjects who were carefully matched for sex, age, and body m
ass index to serve as the control group (18 men and 8 women, 28.4 +/-
1.6 yr of age, 22.6 +/- 0.7 kg/m2), for a controlled, prospective stud
y. Sequential euglycemichypoglycemic clamps were performed with stable
glycemic plateaus of 5.6, 3.3, 2.2, and 1. 7 mM, at which the patient
s' and healthy control subjects' neurophysiological functions were eva
luated. The methodological armamentarium included the measurement of b
rainstem auditory, middle-latency auditory, and somatosensory evoked p
otentials that assessed conduction velocity in corresponding neural st
ructures and information processing in die midbrain and auditory corte
x. RESULTS- Multiple analysis of variance revealed a significant overa
ll difference of brainstem auditory evoked potential latencies during
euglycemia between the study group and healthy control group (F = 3.41
, P < 0.03), which was mainly attributable to latency delays of wave I
II (F = 6.60, P < 0.02), V (F = 9.19, P < 0.01), and interpeak latency
I-V (F = 2.82, P < 0.07). Repeated analysis of variance measures dete
cted a significant latency delay of the major wave P. of the middle-la
tency auditory evoked potentials during hypoglycemia (F = 4.4, P < 0.0
2), which rapidly returned to normal after reinstitution of euglycemia
. CONCLUSIONS- In IDDM patients, chronic, structural CNS changes alrea
dy appear at the brainstem level during euglycemia. Functional, revers
ible CNS changes, however, seem to emerge during acute deviation from
glucose homeostasis in more rostral brain regions.